In Association for Molecular Pathology v. Myriad Genetics, Inc., the U.S. Supreme Court today ruled unanimously that unaltered human genes cannot be patented. Rutgers School of Law–Newark Professor Sabrina Safrin can explain the issues addressed by the Court and the likely impact of the decision.
Professor Sabrina Safrin teaches and writes in the areas of public international law, patent law, and international law and science. Her publications include “Chain Reaction: How Property Begets Property” and “Hyperownership in a Time of Biotechnological Promise: The International Conflict to Control the Building Blocks of Life,” which received the Francis Deak Prize from the American Society of International Law. Prior to joining the Rutgers faculty, she was an attorney-adviser at the Office of the Legal Adviser, U.S. Department of State, where she helped negotiate treaties and international instruments pertaining to biotechnology, genetic resources and biological diversity.
Contact Professor Safrin at 973-986-4651 or 973-762-4763.| Read Story